815a. Group Leader
Session: Poster Discussion Round: Antiretroviral Therapy and Management
Thursday, October 4, 2018: 12:30 PM
Room: S Poster Hall
Babafemi Taiwo, MBBS, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL

Trained at the College of Medicine, University of Ibadan, Dr. Babafemi Olapoju Taiwo is the Gene Stollerman Professor of Medicine, Chief of the Division of Infectious, and Director for Research in Africa Center for Global Health, Northwestern University Chicago. Dr. Taiwo’s research is focused on discovering novel antiretroviral strategies to optimize HIV virologic control, reduce toxicities, and mitigate end-organ consequences of HIV-mediated inflammation and immune activation. His pioneering research on two-drug antiretroviral strategy paved the way for the first paradigm shift in antiretroviral therapy composition in over two decades. Until recently, he was Chair of the Antiretroviral Strategies Committee of the NIH-funded AIDS Clinical Trials Group (ACTG). He is currently on the Executive Committee of the ACTG and is an Advisory Board Member of the NIH Office of AIDS Research. Dr. Taiwo has made substantial contributions to HIV research and research capacity development in Nigeria. He is PI of the NIH-funded Multidisciplinary NeuroAIDS Research and Training Program at the University of Ibadan, which aims to enable emergence of broad and integrated NeuroAIDS research expertise in Nigeria. With over 100 HIV/AIDS publications and 10 books/chapters. Dr Taiwo serves as an Editor for the Journal of Antimicrobial Chemotherapy, the official journal of the British Society for Antimicrobial Chemotherapy.


B. Taiwo, viiv: Consultant , Consulting fee and Grant recipient . gilead: Consultant , Consulting fee . merck: Consultant , Consulting fee .

Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.